Kallikreins when activating bradykinin B2 receptor induce its redistribution on plasma membrane

International Immunopharmacology

Volumn 2, Issue 13-14, 2002, Pages 1795-1806

  Hecquet, Claudie ^a   Becker, Robert P ^a   Tan, Fulong ^a   Erdös, Ervin G ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Bradykinin; Kallikreins; Plasma membrane

Indexed keywords

APROTININ; BRADYKININ B2 RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE; GREEN FLUORESCENT PROTEIN; ICATIBANT; KALLIKREIN; PROTEINASE; SERINE PROTEINASE; TRYPSIN; ARACHIDONIC ACID; BRADYKININ; BRADYKININ RECEPTOR; CALCIUM; PHOTOPROTEIN; PREKALLIKREIN; RECOMBINANT PROTEIN;

ANIMAL CELL; ARTICLE; CELL MEMBRANE; CHO CELL; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; ENZYME ACTIVATION; ENZYME LOCALIZATION; ENZYME MECHANISM; ENZYME STABILITY; FLUORESCENCE MICROSCOPY; GENETIC TRANSFECTION; HUMAN; INTERNALIZATION; NONHUMAN; PANCREAS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; ANIMAL; BINDING COMPETITION; CELL LINE; GENETICS; METABOLISM; RADIOASSAY; SITE DIRECTED MUTAGENESIS;

ANIMALS; ARACHIDONIC ACID; BINDING, COMPETITIVE; BRADYKININ; CALCIUM; CELL LINE; CELL MEMBRANE; GREEN FLUORESCENT PROTEINS; HUMANS; KALLIKREINS; LUMINESCENT PROTEINS; MICROSCOPY, CONFOCAL; MUTAGENESIS, SITE-DIRECTED; PREKALLIKREIN; RADIOLIGAND ASSAY; RECEPTOR, BRADYKININ B2; RECEPTORS, BRADYKININ; RECOMBINANT PROTEINS; TRANSFECTION;

EID: 0036893339     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1567-5769(02)00176-5     Document Type: Article

References (24)

1. Bhoola K.D., Figueroa C.D., Worthy K. Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol. Rev. 44:1992;1-80.
2. Erdös E.G. Bradykinin, kallidin and kallikrein. Handb. Exp. Pharmacol. vol. XXV:1979;1-817 Springer, Heidelberg. Supplement to.
3. Rocha e Silva M. The physiological significance of bradykinin. Ann. N.Y. Acad. Sci. 104:1963;190-211.
4. Werle E., Götze W., Keppler A. Über die Wirkung des Kallikreins auf den isolierten Darm und über eine neue darmkontrahierende Substanz. Biochem. Z. 289:1937;217-233.
5. q subfamily of guanine nucleotide-binding regulatory protein α subunits attenuate activation of phosphatidylinositol 4,5-bisphosphate hydrolysis by hormones. J. Biol. Chem. 266:1991;20519-20524.
6. Liao J.K., Homcy C.J. The G proteins of the Gαi and Gαq family couple the bradykinin receptor to the release of endothelium-derived relaxing factor. J. Clin. Invest. 92:1993;2168-2172.
7. Félétou M., Vanhotte P.M. Endothelium-dependent hyperpolarization of canine coronary smooth muscle. Br. J. Pharmacol. 93:1988;515-524.
8. 2 receptor is activated by kallikrein and other serine proteases. Mol. Pharmacol. 58(4):2000;828-836.
9. Takada Y., Skidgel R.A., Erdös E.G. Purification of human prokallikrein. Identification of the site of activation by the metalloproteinase thermolysin. Biochem. J. 232:1985;851-858.
10. Abe M., Nakamura F., Tan F., Deddish P.A., Colley K.J., Becker R.P.et al. Expression of rat kallikrein and epithelial polarity in transfected Madin-Darby canine kidney cells. Hypertension. 26:1995;891-898.
11. 2 receptors and ACE in CHO cells. Circ. Res. 81:1997;848-856.
12. 2 receptor. Hypertension. 33:1999;835-843.
13. Salvesen G.S., Cathepsin G. Barrett A.J., Rawlings N.D., Woessner F. Handbook of proteolytic enzymes. 1998;60-62 Academic Press, New York.
14. Molino M., Blanchard N., Belmonte E., Tarver A.P., Abrams C., Hoxie A.J.et al. Proteolysis of the human platelet and endothelial cell thrombin receptor by neutrophil-derived cathepsin G. J. Biol. Chem. 270:1994;11168-11175.
15. Skidgel R.A., Jackman H.L., Erdös E.G. Metabolism of substance P and bradykinin by human neutrophils. Biochem. Pharmacol. 41:1991;1335-1344.
16. Hess J.F., Borkowski J.A., Young J.S., Strader C.D., Ransom R.W. Cloning and pharmacological characterization of a human bradykinin (BK-2) receptor. Biochem. Biophys. Res. Commun. 184:1992;260-268.
17. Dery O., Corvera C.U., Steinhoff M., Bunnett N.W. Proteinase-activated receptors: novel mechanisms of signaling by serine proteases. Am. J. Physiol. 274:1998;C1429-C1452.
18. Kraut H., Frey E.K., Werle E. Über die Inaktivierung des Kallikreins. Hoppe-Seyler Z. Physiol. Chem. 192:1930;1-21.
19. Kassel B., Laskowski M. Sr. The basic trypsin inhibitor of bovine pancreas: V. The disulfide linkages. Biochem. Biophys. Res. Commun. 20(4):1965;463-468.
20. Bohm S.K., McConalogue K., Wuyi K., Bunnett N.W. Proteinase-activated receptors: new functions for old enzymes. News Physiol. Sci. 13:1998;231-240.
21. Yamada K., Erdös E.G. Kallikrein and prekallikrein of the isolated basolateral membrane of rat kidney. Kidney Int. 22:1982;331-337.
22. Haasemann M., Cartaud J., Müller-Esterl W., Dunia I. Agonist-induced redistribution of bradykinin B2 receptor in caveolae. J. Cell Sci. 111:1998;917-928.
23. de Weerd W.F., Leeb-Lundberg L.M. Bradykinin sequesters B2 bradykinin receptors and the receptor-coupled Gα subunits Gαq and Gαi in caveolae in DDT1 MF-2 smooth muscle cells. J. Biol. Chem. 272:1997;17858-17866.
24. Bachvarov D., Houle S., Bachvarova M., Bouthillier J., Adam A., Marceau F. Bradykinin B2 receptor endocytosis, recycling, and downregulation assessed using green fluorescent protein conjugates. J. Pharmacol. Exp. Ther. 297:2001;19-26.